You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
JNJ 10198409 New
Potent platelet-derived growth factor receptor (PDGFR) inhibitor (IC50 values are 4.2 and 45 nM for PDGFRβ and PDGFRα, respectively). Also inhibits c-Abl, Lck, c-Src and Fyn kinases (IC50 values are 22, 100, 185 and 378 nM respectively). Displays antiproliferative activity in multiple tumor cell lines. Accelerates down regulation of fibroblast genes in reprogramming of human fibroblasts into functional cardiomyocytes, within 9C cocktail.
Sold with the permission of Janssen Pharmaceutica N.V.
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 325.34. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||3.07 mL||15.37 mL||30.74 mL|
|5 mM||0.61 mL||3.07 mL||6.15 mL|
|10 mM||0.31 mL||1.54 mL||3.07 mL|
|50 mM||0.06 mL||0.31 mL||0.61 mL|
References are publications that support the biological activity of the product.
Ho et al (2005) (6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamines: platelet-derived growth factor receptor tyrosine kinase inhibitors with broad antiproliferative activity against tumor cells. J.Med.Chem. 29 8163 PMID: 16366598
Cao et al (2016) Conversion of human fibroblasts into functional cardiomyocytes by small molecules. Science. 352 1216 PMID: 27127239
If you know of a relevant reference for JNJ 10198409, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: JNJ 10198409, JNJ 10198409 supplier, JNJ10198409, stem, cell, reprogramming, 9C, cocktail, cardiomyocytes, myocytes, platelet-derived, growth, factor, receptor, alpha, beta, inhibitors, inhibits, PDGFR, PDGFRb, PDGFRa, Src, Kinases, Other, Stem, Cell, Reprogramming, 6976, Tocris Bioscience
Citations for JNJ 10198409
Citations are publications that use Tocris products.
Currently there are no citations for JNJ 10198409. Do you know of a great paper that uses JNJ 10198409 from Tocris? Please let us know.
Reviews for JNJ 10198409
There are currently no reviews for this product. Be the first to review JNJ 10198409 and earn rewards!
Have you used JNJ 10198409?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Protocols for JNJ 10198409
The following protocol features additional information for the use of JNJ 10198409 (Cat. No. 6976).
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.